 MONMOUTH JUNCTION, N.J., June 1, 2021 PRNewswire -- CytoSorbents Corporation NASDAQ: CTSO, a critical care therapy leader commercializing its CytoSorb blood purification technology to treat deadly conditions in critically ill and cardiac surgery patients around the world, announces the appointment of Terri Anne Powers, MBA, IRC, as Vice President of Investor Relations and Corporate Communications effective today. 